Literature DB >> 3480377

Lung cancer mortality (1950-80) in relation to radon daughter exposure in a cohort of workers at the Eldorado Port Radium uranium mine: possible modification of risk by exposure rate.

G R Howe1, R C Nair, H B Newcombe, A B Miller, J D Burch, J D Abbatt.   

Abstract

A cohort study of 2,103 workers employed between 1942 and 1960 at a uranium mine in the Northwest Territories, Canada, was conducted. A total of 57 lung cancer deaths was observed (expected = 24.73, P less than .0001). There was a highly significant linear relationship between exposure and increased risk of lung cancer, giving estimates for the relative and attributable risk coefficients of 0.27 per working level month (WLM) and 3.10 per WLM per 10(6) person-years. These risk coefficients were substantially less than those estimated from the experience of miners in the Beaverlodge mine, which have previously been reported. Any biases in the present estimates are likely to have been upward, and therefore they probably represent an upper limit. The major difference between the two mine cohorts is in the exposure rate, since the Port Radium miners were exposed to much greater concentrations of radon daughters than the Beaverlodge miners. It is postulated that risk of lung cancer from radon daughter exposure may be modified by exposure rate, for which hypothesis there is some support from other epidemiologic data.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480377

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952-87.

Authors:  A Woodward; D Roder; A J McMichael; P Crouch; A Mylvaganam
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

2.  Leukemia, lymphoma and multiple myeloma mortality (1950-1999) and incidence (1969-1999) in the Eldorado uranium workers cohort.

Authors:  Lydia B Zablotska; Rachel S D Lane; Stanley E Frost; Patsy A Thompson
Journal:  Environ Res       Date:  2014-02-28       Impact factor: 6.498

3.  Radon-associated lung cancer risk among French uranium miners: modifying factors of the exposure-risk relationship.

Authors:  Blandine Vacquier; Agnès Rogel; Klervi Leuraud; Sylvaine Caer; Alain Acker; Dominique Laurier
Journal:  Radiat Environ Biophys       Date:  2008-10-24       Impact factor: 1.925

4.  What are the health costs of uranium mining? A case study of miners in Grants, New Mexico.

Authors:  Benjamin A Jones
Journal:  Int J Occup Environ Health       Date:  2014-10

5.  Lung cancer mortality (1950-1999) among Eldorado uranium workers: a comparison of models of carcinogenesis and empirical excess risk models.

Authors:  Markus Eidemüller; Peter Jacob; Rachel S D Lane; Stanley E Frost; Lydia B Zablotska
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 6.  Models for the analysis of radon-exposed populations.

Authors:  J H Lubin
Journal:  Yale J Biol Med       Date:  1988 May-Jun

7.  Ionizing radiation: future etiologic research and preventive strategies.

Authors:  S C Darby; P D Inskip
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

Review 8.  Radon exposure and lung cancer: risk in nonsmokers among cohort studies.

Authors:  Sung-Soo Oh; Sangbaek Koh; Heetae Kang; Jonggu Lee
Journal:  Ann Occup Environ Med       Date:  2016-03-09

9.  Mortality of a cohort of French uranium miners exposed to relatively low radon concentrations.

Authors:  M Tirmarche; A Raphalen; F Allin; J Chameaud; P Bredon
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

10.  Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method.

Authors:  C B Ge; J Kim; F Labrèche; E Heer; C Song; V H Arrandale; M Pahwa; C E Peters; P A Demers
Journal:  Int Arch Occup Environ Health       Date:  2020-03-30       Impact factor: 3.015

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.